Fusion Pharmaceuticals skyrockets, AstraZeneca dips following acquisition announcement Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Fusion Pharmaceuticals (FUSN) up 98% after the company announced a definitive agreement to be acquired by AstraZeneca (AZN) for a price of $21.00 per share in cash at closing plus a non-transferable contingent value right, or CVR, of $3.00 per share in cash payable upon the achievement of a specified regulatory milestone
- Crinetics (CRNX) up 13% after reporting the PATHFNDR-2 study evaluating the efficacy and safety of investigational paltusotine for the treatment of acromegaly met all primary endpoints
- Unilever (UL) up 2% after announcing the planned separation of its Ice Cream segment and the launch of a productivity program
UP AFTER EARNINGS -
- Core & Main (CNM) up 2%
- Tencent Music (TME) up 1%
- National CineMedia (NCMI) up 19%
DOWN AFTER EARNINGS -
LOWER -
- Supermicro (SMCI) down 10% after filing to sell 2M shares of common stock
- AstraZeneca (AZN) down 1% after the company announced a deal to acquire all of Fusion's outstanding shares for a price of $21.00 per share in cash at closing plus a non-transferable contingent value right of $3.00 per share in cash
- Nvidia (NVDA) down 3% after the company hosted its keynote address yesterday at the start of its GPU Technology Conference
Symbols:
FUSN UL CRNX CNM TME NCMI DLO AZN SMCI - $1,000.19 /
-68.86 (-6.44%)
NVDA - $884.57 /
+6.205 (+0.71%)
Keywords: Fly Intel, Wall Street, Top Stories, Stocks